Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOTOXIC AGENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jain, KK
      Use of bacteria as anticancer agents

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Gardner, RV; McKinnon, E; Astle, CM
      Analysis of the stem cell sparing properties of cyclophosphamide

      EUROPEAN JOURNAL OF HAEMATOLOGY
    3. Hall, IH; Barnes, BJ; Ward, ES; Wheaton, JR; Shaffer, KA; Cho, SE; Warren, AE
      Targeting of human Tmolt(4) leukemic type IIIMP dehydrogenase by cyclic imide related derivatives

      ARCHIV DER PHARMAZIE
    4. Gardner, RV; Begue, R; McKinnon, E
      The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) onprimitive hematopoietic stem cell (PHSC) function and numbers, after chemotherapy

      EXPERIMENTAL HEMATOLOGY
    5. Ponticelli, C; Passerini, P
      Alternative treatments for focal and segmental glomerular sclerosis

      CLINICAL NEPHROLOGY
    6. Riise, T; Jacobsen, BK; Gran, JT
      Changes in therapy of rheumatoid arthritis during the period 1979 to 1996

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    7. Braumann, C; Ordemann, J; Wildbrett, P; Jacobi, CA
      Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats

      CLINICAL & EXPERIMENTAL METASTASIS
    8. Sugikawa, E; Tsunoda, S; Nakanishi, N; Ohashi, M
      9-hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein

      ANTICANCER RESEARCH
    9. Atzpodien, J; Kirchner, H; Illiger, HJ; Metzner, B; Ukena, D; Schott, H; Funke, PJ; Gramatzki, M; von Jurgensom, S; Wandert, T; Patzelt, T; Reitz, M
      IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastaticrenal cell carcinoma: long-term results of a controlled randomized clinical trial

      BRITISH JOURNAL OF CANCER
    10. Ryan, CJ; Wilding, G
      Angiogenesis inhibitors - New agents in cancer therapy

      DRUGS & AGING
    11. Naumann, R; Wozel, G
      Transverse leukonychia following chemotherapy in a patient with Hodgkin's disease

      EUROPEAN JOURNAL OF DERMATOLOGY
    12. van Os, R; Robinson, S; Sheridan, T; Mauch, PM
      Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal

      STEM CELLS
    13. Attur, MG; Patel, R; Thakker, G; Vyas, P; Levartovsky, D; Patel, P; Naqvi, S; Raza, R; Patel, K; Abramson, D; Bruno, G; Abramson, SB; Amin, AR
      Differential anti-inflammatory effects of immunosuppressive drugs: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE(2) production

      INFLAMMATION RESEARCH
    14. Wang, XL; Brekken, KB; Siebke, EM; Stokke, G; Sorlid, HK; Benestad, HB
      Granulocytopoiesis versus cytokine activities in peritoneal diffusion chamber cultures in the mouse

      EUROPEAN JOURNAL OF HAEMATOLOGY
    15. Solary, E; Droin, N; Bettaieb, A; Corcos, L; Dimanche-Boitrel, MT; Garrido, C
      Positive and negative regulation of apoptotic pathways by cytotoxic agentsin hematological malignancies

      LEUKEMIA
    16. Robinson, SN; Freedman, AS; Neuberg, DS; Nadler, M; Mauch, PM
      Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+),CD34(+)38(-), and week-6 CAFC assays predict poor engraftment

      EXPERIMENTAL HEMATOLOGY
    17. Shbarou, RM; Chao, NJ; Morgenlander, JC
      Cyclosporin A-related cerebral vasculopathy

      BONE MARROW TRANSPLANTATION
    18. Jacobi, CA
      The role of tumoricidal agents in the prevention of port wound tumors

      NEW ASPECTS OF HIGH TECHNOLOLGY IN MEDICINE
    19. Zunino, F; Cassinelli, G; Polizzi, D; Perego, P
      Molecular mechanisms of resistance to taxanes and therapeutic implications

      DRUG RESISTANCE UPDATES
    20. Girod, CE; Schwarz, MI
      The lung in mixed connective tissue disease

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    21. Kaczmarek, L; Peczynska-Czoch, W; Osiadacz, J; Mordarski, M; Sokalski, WA; Boratynski, J; Marcinkowska, E; Glazman-Kusnierczyk, H; Radzikowski, C
      Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY
    22. Schinzer, D; Bauer, A; Bohm, OM; Limberg, A; Cordes, M
      Total synthesis of (-)-epothilone A

      CHEMISTRY-A EUROPEAN JOURNAL
    23. Schinzer, D; Bauer, A; Schieber, J
      Syntheses of (-)-epothilone B

      CHEMISTRY-A EUROPEAN JOURNAL
    24. Shulman, LN; Buswell, L; Riese, N; Doherty, N; Loeffler, JS; von Roemeling, RW; Coleman, CN
      Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    25. Osiadacz, J; Kaczmarek, L; Opolski, A; Wietrzyk, J; Marcinkowska, E; Biernacka, K; Radzikowski, C; Jon, M; Peczynska-Czoch, W
      Microbial conversion of methyl- and methoxy-substituted derivatives of 5H-indolo[2,3-b]quinoline as a method of developing novel cytotoxic agents

      ANTICANCER RESEARCH
    26. Legros, MH; Bourget, P; Demirdjian, S; Osmond, S; Hartmann, O
      A safety procedure devoted to the orally administration of cytotoxic agents

      THERAPIE
    27. VANDERVEEN AH; EGGERMONT AMM; TENHAGEN TLM
      STEALTH(R) LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOLID TUMOR TREATMENT

      International journal of pharmaceutics
    28. KACZMAREK L; PECZYNSKACZOCH W; OPOLSKI A; WIETRZYK J; MARCINKOWSKA E; BORATYNSKI J; OSIADACZ J
      THOXY-5,6,11-TRIMETHYL-6H-INDOLO[2,3-B]QUINOLINIUM AND THYL-5,6,11-TRIMETHYL-6H-INDOLO[2,3-B]QUINOLINIUM, THOXY-5,6,11-TRIMETHYL-6H-INDOLO[2,3-B]QUINOLINIUM DERIVATIVES AS NOVEL CYTOTOXIC AGENTS AND DNA TOPOISOMERASE-II INHIBITORS

      Anticancer research
    29. QIN XQ; RUNKEL L; DECK C; DEDIOS C; BARSOUM J
      INTERFERON-BETA INDUCES S-PHASE ACCUMULATION SELECTIVELY IN HUMAN TRANSFORMED-CELLS

      Journal of interferon & cytokine research
    30. WALTHER W; WENDT J; STEIN U
      EMPLOYMENT OF THE MDR1 PROMOTER FOR THE CHEMOTHERAPY-INDUCIBLE EXPRESSION OF THERAPEUTIC GENES IN CANCER GENE-THERAPY

      Gene therapy
    31. KONJEVIC G; RUSOV C; ZIVKOVIC R
      THE EFFECT OF CERTAIN CYTOTOXIC AGENTS ON THE PROLIFERATION OF BONE-MARROW CELLS OF CHICKENS WITH ERYTHROLEUKEMIA

      Acta veterinaria
    32. HUGOSSON J; BERGDAHL S; CARLSSON G; FROSING R; NORLEN L; GUSTAVSSON B
      EFFECTS OF INTRAVESICAL INSTILLATION OF 5-FLUOROURACIL AND INTERFERONIN PATIENTS WITH RECURRENT SUPERFICIAL URINARY-BLADDER CARCINOMA - A CLINICAL AND PHARMACODYNAMIC STUDY

      Scandinavian journal of urology and nephrology
    33. HALL IH; WYRICK SD
      CYTOXICITY OF -DICHLORO-9A-N-PROPYL-2,3,9,9A-TETRAHYDRO-3-OXO-1H FLUOREN-7-YL)OXY] ACETIC-ACID, AN AGENT KNOWN TO REDUCE BRAIN EDEMA

      Biomedicine & pharmacotherapy
    34. ZELLER V; COHEN P; PRIEUR AM; GUILLEVIN L
      CYCLOSPORINE-A THERAPY IN REFRACTORY JUVENILE DERMATOMYOSITIS - EXPERIENCE AND LONG-TERM FOLLOW-UP OF 6 CASES

      Journal of rheumatology
    35. VODOVOZOVA EL; NIKOLSKII PY; MIKHALEV II; MOLOTKOVSKY YG
      LIPID DERIVATIVES OF SARCOLYSINE, METHOTR EXATE, AND RUBOMYCIN

      Bioorganiceskaa himia
    36. STEEL GG
      FROM TARGETS TO GENES - A BRIEF-HISTORY OF RADIOSENSITIVITY

      Physics in medicine and biology
    37. NAGY A; ARMATIS P; SCHALLY AV
      HIGH-YIELD CONVERSION OF DOXORUBICIN TO 2-PYRROLINODOXORUBICIN, AN ANALOG 500-1000 TIMES MORE POTENT - STRUCTURE-ACTIVITY RELATIONSHIP OF DAUNOSAMINE-MODIFIED DERIVATIVES OF DOXORUBICIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. LEE KE
      INFLUENCE OF CHEMOTHERAPEUTIC-AGENTS ON THE PROLIFERATION OF CAPILLARY ENDOTHELIAL-CELLS AND TUMOR ANGIOGENESIS IN MURINE BLADDER-CANCER

      International journal of oncology
    39. SCULLY C
      ORAL PRECANCER - PREVENTIVE AND MEDICAL APPROACHES TO MANAGEMENT

      European journal of cancer. Part B, Oral oncology
    40. KAPLAN HJ; FOSTER CS
      CORTICOSTEROID-SPARING STRATEGIES IN THE TREATMENT OF RETINAL VASCULITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      Retina
    41. VALLURI S; MOORTHY RS; KHAN A; RAO NA
      COMBINATION TREATMENT OF INTRAOCULAR LYMPHOMA

      Retina
    42. MOORTHY RS; INOMATA H; RAO NA
      VOGT-KOYANAGI-HARADA SYNDROME

      Survey of ophthalmology
    43. MOGA I; FORMIGA F; CANET R; PAC M; MITJAVILA F; PUJOL R
      INFECTION WITH HERPES-ZOSTER VIRUS IN PAT IENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

      Revista Clinica Espanola
    44. ALPERN RJ
      SOUTHWESTERN INTERNAL-MEDICINE CONFERENCE - VASCULITIS - ITS TIME TO RECLASSIFY

      The American journal of the medical sciences
    45. DEBRAUD F; BAJETTA E; ZAMPINO MG; NOLE F; LONGHI A; ZILEMBO N; COLLEONI M
      CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA (REVIEW)

      Oncology Reports
    46. PETERSEN PM; HANSEN SW; GIWERCMAN A; RORTH M; KAKKEBAEK NE
      DOSE-DEPENDENT IMPAIRMENT OF TESTICULAR FUNCTION IN PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY FOR GERM-CELL CANCER

      Annals of oncology
    47. ONAT H; INANC S; KARALOGLU D; ERTURK N; DALAY N; YASASEVER V
      ACUTE COAGULATION CHANGES DURING CYTOTOXIC CHEMOTHERAPY

      Journal of experimental & clinical cancer research
    48. SCHALLER JG
      AGGRESSIVE TREATMENT IN CHILDHOOD RHEUMATIC DISEASES

      Clinical and experimental rheumatology
    49. DOHERTY N; HANCOCK SL; KAYE S; COLEMAN CN; SHULMAN L; MARQUEZ C; MARISCAL C; RAMPLING R; SENAN S; ROEMELING RV
      MUSCLE CRAMPING IN PHASE-I CLINICAL-TRIALS OF TIRAPAZAMINE (SR-4233) WITH AND WITHOUT RADIATION

      International journal of radiation oncology, biology, physics
    50. TEICHER BA; SCHWARTZ JL; HOLDEN SA; ARA G; NORTHEY D
      IN-VIVO MODULATION OF SEVERAL ANTICANCER AGENTS BY BETA-CAROTENE

      Cancer chemotherapy and pharmacology
    51. JANSEN R; IRSCHIK H; REICHENBACH H; WRAY V; HOFLE G
      ANTIBIOTICS FROM GLIDING BACTERIA .59. DISORAZOLES, HIGHLY CYTOTOXIC METABOLITES FROM THE SORANGICIN-PRODUCING BACTERIUM SORANGIUM-CELLULOSUM, STRAIN SO CE12

      Liebigs Annalen der Chemie
    52. NEBEN S; HEMMAN S; MONTGOMERY M; FERRARA J; MAUCH P
      HEMATOPOIETIC STEM-CELL DEFICIT OF TRANSPLANTED BONE-MARROW PREVIOUSLY EXPOSED TO CYTOTOXIC AGENTS

      Experimental hematology
    53. ENDERS D; FINKAM M
      1ST SYNTHESIS OF THE CYTOTOXIC AND ANTIFUNGAL C-14 AMINE (2S,3E,5Z)-2-AMINO-3,5,13-TETRADECATRIENE ISOLATED FROM THE NEW-ZEALAND ASCIDIAN PSEUDODISTOMA-NOVAEZELANDIAE

      Liebigs Annalen der Chemie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:26:31